Do analysts recommend RPID or BFRG?

Rapid Micro Biosystems currently has a consensus price target of $5.00, indicating a potential upside of 459.60%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, research analysts plainly believe Rapid Micro Biosystems is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rapid Micro Biosystems 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75 Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to HBIO or BFRG?

In the previous week, Bullfrog AI had 2 more articles in the media than Harvard Bioscience. MarketBeat recorded 4 mentions for Bullfrog AI and 2 mentions for Harvard Bioscience. Harvard Bioscience's average media sentiment score of 0.61 beat Bullfrog AI's score of -0.12 indicating that Harvard Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harvard Bioscience 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts prefer BFRG or BNGO?

Bionano Genomics has a consensus target price of $6.00, suggesting a potential upside of 318.12%. Given Bionano Genomics' stronger consensus rating and higher probable upside, analysts plainly believe Bionano Genomics is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Bionano Genomics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is BFRG or BNGO more profitable?

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -106.58%. Bionano Genomics' return on equity of -78.78% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% Bionano Genomics -106.58% -78.78% -48.54%

Do analysts recommend VIVS or BFRG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VivoSim Labs 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is VIVS or BFRG more profitable?

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity. Company Net Margins Return on Equity Return on Assets VivoSim Labs -11,016.07% -612.23% -177.02% Bullfrog AI N/A -150.36% -127.98%

Does the media favor VIVS or BFRG?

In the previous week, VivoSim Labs had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 5 mentions for VivoSim Labs and 4 mentions for Bullfrog AI. VivoSim Labs' average media sentiment score of 0.90 beat Bullfrog AI's score of -0.12 indicating that VivoSim Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment VivoSim Labs 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Do analysts recommend BFRG or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is BFRG or ISPC more profitable?

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -2,445.40%. Bullfrog AI's return on equity of -150.36% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -150.36% -127.98% iSpecimen -2,445.40% -524.39% -140.42%

Does the media prefer BFRG or ISPC?

In the previous week, Bullfrog AI had 2 more articles in the media than iSpecimen. MarketBeat recorded 4 mentions for Bullfrog AI and 2 mentions for iSpecimen. iSpecimen's average media sentiment score of 0.90 beat Bullfrog AI's score of -0.12 indicating that iSpecimen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral iSpecimen 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Bullfrog AI (BFRG) Competitors

$0.65 0.00 (0.00%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.64 -0.01 (-1.70%)

As of 08:51 AM Eastern

Compare

BFRG vs. RPID, HBIO, BNGO, VIVS, and ISPC

Should you buy Bullfrog AI stock or one of its competitors? Bullfrog AI's main competitors and comparable companies include Rapid Micro Biosystems (RPID), Harvard Bioscience (HBIO), Bionano Genomics (BNGO), VivoSim Labs (VIVS), and iSpecimen (ISPC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Bullfrog AI compare to Rapid Micro Biosystems?

Rapid Micro Biosystems (NASDAQ:RPID) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 12.7% of Rapid Micro Biosystems shares are held by company insiders. Comparatively, 14.7% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Bullfrog AI has lower revenue, but higher earnings than Rapid Micro Biosystems. Bullfrog AI is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rapid Micro Biosystems	$33.59M	1.33	-$47.12M	-$1.12	N/A
Bullfrog AI	$120K	99.81	-$6.50M	-$0.46	N/A

Rapid Micro Biosystems currently has a consensus price target of $5.00, indicating a potential upside of 459.60%. Given Rapid Micro Biosystems' stronger consensus rating and higher probable upside, research analysts plainly believe Rapid Micro Biosystems is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rapid Micro Biosystems	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Bullfrog AI had 3 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 4 mentions for Bullfrog AI and 1 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.29 beat Bullfrog AI's score of -0.12 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.

Company	Overall Sentiment
Rapid Micro Biosystems	Positive
Bullfrog AI	Neutral

Rapid Micro Biosystems has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.73, meaning that its stock price is 373% less volatile than the broader market.

Bullfrog AI has a net margin of 0.00% compared to Rapid Micro Biosystems' net margin of -145.56%. Bullfrog AI's return on equity of -150.36% beat Rapid Micro Biosystems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rapid Micro Biosystems	-145.56%	-177.04%	-73.12%
Bullfrog AI	N/A	-150.36%	-127.98%

Summary

Rapid Micro Biosystems beats Bullfrog AI on 10 of the 17 factors compared between the two stocks.

How does Bullfrog AI compare to Harvard Bioscience?

Harvard Bioscience (NASDAQ:HBIO) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends, media sentiment and earnings.

Bullfrog AI has a net margin of 0.00% compared to Harvard Bioscience's net margin of -11.86%. Harvard Bioscience's return on equity of -33.13% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-11.86%	-33.13%	-4.80%
Bullfrog AI	N/A	-150.36%	-127.98%

Harvard Bioscience has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.73, meaning that its stock price is 373% less volatile than the broader market.

In the previous week, Bullfrog AI had 2 more articles in the media than Harvard Bioscience. MarketBeat recorded 4 mentions for Bullfrog AI and 2 mentions for Harvard Bioscience. Harvard Bioscience's average media sentiment score of 0.61 beat Bullfrog AI's score of -0.12 indicating that Harvard Bioscience is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Harvard Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Bullfrog AI has lower revenue, but higher earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$86.55M	0.43	-$56.70M	-$2.31	N/A
Bullfrog AI	$120K	99.81	-$6.50M	-$0.46	N/A

Harvard Bioscience presently has a consensus price target of $6.75, suggesting a potential downside of 18.08%. Given Harvard Bioscience's stronger consensus rating and higher possible upside, equities research analysts plainly believe Harvard Bioscience is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

80.9% of Harvard Bioscience shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 17.0% of Harvard Bioscience shares are held by company insiders. Comparatively, 14.7% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Harvard Bioscience beats Bullfrog AI on 10 of the 16 factors compared between the two stocks.

How does Bullfrog AI compare to Bionano Genomics?

Bullfrog AI (NASDAQ:BFRG) and Bionano Genomics (NASDAQ:BNGO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 11.4% of Bionano Genomics shares are owned by institutional investors. 14.7% of Bullfrog AI shares are owned by company insiders. Comparatively, 0.7% of Bionano Genomics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bullfrog AI has a net margin of 0.00% compared to Bionano Genomics' net margin of -106.58%. Bionano Genomics' return on equity of -78.78% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
Bionano Genomics	-106.58%	-78.78%	-48.54%

Bullfrog AI has higher earnings, but lower revenue than Bionano Genomics. Bullfrog AI is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	99.81	-$6.50M	-$0.46	N/A
Bionano Genomics	$28.51M	0.59	-$26.40M	-$3.02	N/A

Bionano Genomics has a consensus target price of $6.00, suggesting a potential upside of 318.12%. Given Bionano Genomics' stronger consensus rating and higher probable upside, analysts plainly believe Bionano Genomics is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Bionano Genomics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Bullfrog AI has a beta of -2.73, suggesting that its stock price is 373% less volatile than the broader market. Comparatively, Bionano Genomics has a beta of 1.66, suggesting that its stock price is 66% more volatile than the broader market.

In the previous week, Bullfrog AI had 2 more articles in the media than Bionano Genomics. MarketBeat recorded 4 mentions for Bullfrog AI and 2 mentions for Bionano Genomics. Bionano Genomics' average media sentiment score of 0.46 beat Bullfrog AI's score of -0.12 indicating that Bionano Genomics is being referred to more favorably in the news media.

Company	Overall Sentiment
Bullfrog AI	Neutral
Bionano Genomics	Neutral

Summary

Bionano Genomics beats Bullfrog AI on 10 of the 16 factors compared between the two stocks.

How does Bullfrog AI compare to VivoSim Labs?

VivoSim Labs (NASDAQ:VIVS) and Bullfrog AI (NASDAQ:BFRG) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, VivoSim Labs had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 5 mentions for VivoSim Labs and 4 mentions for Bullfrog AI. VivoSim Labs' average media sentiment score of 0.90 beat Bullfrog AI's score of -0.12 indicating that VivoSim Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VivoSim Labs	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VivoSim Labs	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Bullfrog AI has lower revenue, but higher earnings than VivoSim Labs. Bullfrog AI is trading at a lower price-to-earnings ratio than VivoSim Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VivoSim Labs	$130K	22.98	-$13.84M	-$4.47	N/A
Bullfrog AI	$120K	99.81	-$6.50M	-$0.46	N/A

Bullfrog AI has a net margin of 0.00% compared to VivoSim Labs' net margin of -11,016.07%. Bullfrog AI's return on equity of -150.36% beat VivoSim Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VivoSim Labs	-11,016.07%	-612.23%	-177.02%
Bullfrog AI	N/A	-150.36%	-127.98%

8.2% of VivoSim Labs shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 1.0% of VivoSim Labs shares are held by insiders. Comparatively, 14.7% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

VivoSim Labs has a beta of 1.49, indicating that its share price is 49% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.73, indicating that its share price is 373% less volatile than the broader market.

Summary

Bullfrog AI beats VivoSim Labs on 8 of the 14 factors compared between the two stocks.

How does Bullfrog AI compare to iSpecimen?

Bullfrog AI (NASDAQ:BFRG) and iSpecimen (NASDAQ:ISPC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

Bullfrog AI has a net margin of 0.00% compared to iSpecimen's net margin of -2,445.40%. Bullfrog AI's return on equity of -150.36% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-150.36%	-127.98%
iSpecimen	-2,445.40%	-524.39%	-140.42%

Bullfrog AI has a beta of -2.73, meaning that its share price is 373% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bullfrog AI has higher earnings, but lower revenue than iSpecimen. Bullfrog AI is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$120K	99.81	-$6.50M	-$0.46	N/A
iSpecimen	$1.93M	1.48	-$10.49M	-$56.44	N/A

In the previous week, Bullfrog AI had 2 more articles in the media than iSpecimen. MarketBeat recorded 4 mentions for Bullfrog AI and 2 mentions for iSpecimen. iSpecimen's average media sentiment score of 0.90 beat Bullfrog AI's score of -0.12 indicating that iSpecimen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
iSpecimen	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

1.0% of Bullfrog AI shares are held by institutional investors. Comparatively, 13.6% of iSpecimen shares are held by institutional investors. 14.7% of Bullfrog AI shares are held by insiders. Comparatively, 12.2% of iSpecimen shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Bullfrog AI beats iSpecimen on 9 of the 14 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BFRG vs. The Competition

Export

Metric	Bullfrog AI	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$11.98M	$10.58B	$7.25B	$13.28B
Dividend Yield	N/A	1.45%	2.53%	22.58%
P/E Ratio	-1.40	32.42	275.59	26.13
Price / Sales	99.81	105.94	561.38	72.89
Price / Cash	N/A	27.28	27.30	36.12
Price / Book	3.40	6.49	10.83	6.16
Net Income	-$6.50M	$56.67B	$3.50B	$381.12M
7 Day Performance	8.75%	-2.81%	-1.28%	-1.46%
1 Month Performance	35.74%	9.07%	-4.05%	-3.37%
1 Year Performance	-51.06%	32.01%	7.11%	1.49%

Bullfrog AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BFRG Bullfrog AI	1.4395 of 5 stars	$0.65 flat	N/A	-51.1%	$11.98M	$120K	N/A	17	Short Interest Increase Gap Up
RPID Rapid Micro Biosystems	3.6793 of 5 stars	$0.93 -1.5%	$5.00 +438.8%	-72.2%	$46.55M	$33.59M	N/A	171	Positive News Gap Down
HBIO Harvard Bioscience	1.2782 of 5 stars	$8.54 -0.2%	$6.75 -21.0%	+96.4%	$38.88M	$87.81M	N/A	339
BNGO Bionano Genomics	2.659 of 5 stars	$1.46 +0.7%	$6.00 +311.0%	-26.4%	$17.15M	$28.51M	N/A	97	Short Interest Increase
VIVS VivoSim Labs	0.5523 of 5 stars	$0.19 -4.4%	N/A	-94.1%	$3.20M	$130K	N/A	11

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bullfrog AI (BFRG) Competitors

BFRG vs. RPID, HBIO, BNGO, VIVS, and ISPC

How does Bullfrog AI compare to Rapid Micro Biosystems?

Summary

How does Bullfrog AI compare to Harvard Bioscience?

Summary

How does Bullfrog AI compare to Bionano Genomics?

Summary

How does Bullfrog AI compare to VivoSim Labs?

Summary

How does Bullfrog AI compare to iSpecimen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bullfrog AI (BFRG) Competitors

BFRG vs. RPID, HBIO, BNGO, VIVS, and ISPC

How does Bullfrog AI compare to Rapid Micro Biosystems?

Do insiders & institutionals believe in RPID or BFRG?

Which has stronger valuation and earnings, RPID or BFRG?

Do analysts recommend RPID or BFRG?

Does the media favor RPID or BFRG?

Which has more volatility and risk, RPID or BFRG?

Is RPID or BFRG more profitable?

Summary

How does Bullfrog AI compare to Harvard Bioscience?

Is HBIO or BFRG more profitable?

Which has more risk & volatility, HBIO or BFRG?

Does the media refer more to HBIO or BFRG?

Which has stronger valuation & earnings, HBIO or BFRG?

Do analysts prefer HBIO or BFRG?

Do insiders and institutionals have more ownership in HBIO or BFRG?

Summary

How does Bullfrog AI compare to Bionano Genomics?

Do institutionals & insiders hold more shares of BFRG or BNGO?

Is BFRG or BNGO more profitable?

Which has preferable valuation and earnings, BFRG or BNGO?

Do analysts prefer BFRG or BNGO?

Which has more volatility & risk, BFRG or BNGO?

Does the media favor BFRG or BNGO?

Summary

How does Bullfrog AI compare to VivoSim Labs?

Does the media favor VIVS or BFRG?

Do analysts recommend VIVS or BFRG?

Which has better valuation and earnings, VIVS or BFRG?

Is VIVS or BFRG more profitable?

Do insiders & institutionals hold more shares of VIVS or BFRG?

Which has more risk & volatility, VIVS or BFRG?

Summary

How does Bullfrog AI compare to iSpecimen?

Is BFRG or ISPC more profitable?

Which has more volatility & risk, BFRG or ISPC?

Do analysts recommend BFRG or ISPC?

Which has preferable valuation & earnings, BFRG or ISPC?

Does the media prefer BFRG or ISPC?

Do institutionals and insiders believe in BFRG or ISPC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools